Often, nurses can’t leave their patient’s bedside. With PEPID, they don’t have to.
Skokie, IL. April 29, 2005—PEPID LLC-the world’s leading developer of medical information and support tools-has joined forces with the National Association of Clinical Nurse Specialists (NACNS) to bring PEPID’s portable emergency database to Critical Care Nursing.
“We are excited about the continuing developments of our relationship with NACNS,” says John Wagner, President of PEPID. “Their professional clinical expertise directly involved with our product provides point of care information for specific issues important to Critical Care nurses.”
PEPID has always been a leader when it comes to providing emergency room physicians and nurses with the support back-up they need at point-of-care. PEPID delivers on-the-spot diagnoses and drug interaction warnings, as well as the most up-to-date medical reference content available. The new software developed with NACNS, PEPID™ RN Critical Care (RNCC), is sure to make a fresh impact in the world of healthcare professionals.
Diane Muench, co-author of PEPID RNCC, recognized the demand early on. “Critical care nurses have been using PEPID from the beginning. They have a strong need for instant access to accurate information on the spot,” says Muench. “Often, nurses can’t leave their patient’s bedside. With PEPID, they don’t have to.”
Subscribers to RNCC get everything in PEPID’s acclaimed RN Clinical Companion suite, plus specialty enhancements that critical care nurses will find essential include: managing the ICU environment, hemodynamics, pain/anxiety management in the ICU, critical care assessment, airway management, mechanical ventilation, acid base balance, nosocomial complications, nutrition in the ICU and much more.
Advanced practice nurse authors, designated by the NACNS, have provided the critical care content in the new release. As a result, PEPID RN Critical Care is the only point-of-care reference software specifically designed by critical care nurses for critical care nurses. “It is partnerships like this one that allow PEPID to evolve, expand capabilities, and stay in touch with nursing professionals and their needs,” adds Wagner.
PEPID’s commitment to deliver leading medical information and support tools to point-of-care remains unmatched. Their latest software reflects their drive to stay ahead of the demand and improve healthcare across the country.
About PEPID LLC
PEPID is the nation’s leading producer of fully-integrated medical reference software delivered to point-of-care on a PDA or any Internet-connected device. The firm was founded in 1994 by Dr. Mark Rosenbloom, a board-certified emergency physician and Adjunct Associate Professor of Medicine at Northwestern University’s Feinberg School of Medicine in Chicago, Illinois. Today, the firm continues to pursue medical content excellence, supported by cutting-edge technology and worldwide market expansion. PEPID’s medical information software is designed to provide all medical professionals with instant bedside access to complete reference and decision-support tools. Healthcare practitioners save precious time finding and processing information, and can spend more time with their patients. PEPID software products ─ specifically designed for physicians, nurses, students, paramedics and pharmacists ─ provide access to current clinical and pharmacological information at the point-of-care via handheld devices or an Internet connected PC.
PEPID partners with palmOneTM, Dell TM, the Family Physicians Inquiries NetworkTM , the Oncology Nursing Society, the National Association of Clinical Nurse Specialists, the American Society of Health-System Pharmacists, and many others. More information about PEPID and our products can be found at www.pepid.com
Contact: David Luck, Marketing Communications Manager, 888-321-7828 ext 204, email firstname.lastname@example.org
PEPID™, product names, and logotypes are trade marks of PEPID LLC.
Other product and corporate names may be registered trade marks of their respective owners.
Copyright © 2000-2005. All rights reserved.